Parallax Volatility Advisers, L.P. Provention Bio, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $70,350 - $254,205	10,500 New	10,500 $253,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $283,000 - $416,500	-50,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $335,500 - $552,000	50,000 New	50,000 $422,000
Q1 2021 May 14, 2021	SELL	$10.12 - $19.45 $505,999 - $972,500	-50,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $505,999 - $972,500	50,000 New	50,000 $525,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.